Australia markets closed

LENZ Therapeutics, Inc. (LENZ)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.54-0.15 (-0.85%)
At close: 04:00PM EDT
17.54 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 447.87M
Enterprise value 235.18M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.26
Enterprise value/revenue N/A
Enterprise value/EBITDA -7.99

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3566.92%
S&P500 52-week change 323.89%
52-week high 324.59
52-week low 32.01
50-day moving average 316.69
200-day moving average 37.86

Share statistics

Avg vol (3-month) 3195.44k
Avg vol (10-day) 3398.27k
Shares outstanding 525.53M
Implied shares outstanding 625.75M
Float 89.62M
% held by insiders 15.52%
% held by institutions 181.95%
Shares short (14 June 2024) 41.5M
Short ratio (14 June 2024) 48.49
Short % of float (14 June 2024) 4N/A
Short % of shares outstanding (14 June 2024) 45.88%
Shares short (prior month 15 May 2024) 41.07M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 321 Mar 2024
Ex-dividend date 4N/A
Last split factor 21:7
Last split date 322 Mar 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -75.88M
Net income avi to common (ttm)-73.95M
Diluted EPS (ttm)-2.74
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)213.28M
Total cash per share (mrq)8.35
Total debt (mrq)589k
Total debt/equity (mrq)0.30%
Current ratio (mrq)11.47
Book value per share (mrq)7.76

Cash flow statement

Operating cash flow (ttm)-71.52M
Levered free cash flow (ttm)N/A